Proqr Therapeutics N V Revenue per Employee (PRQR), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Proqr Therapeutics N v   (NASDAQ: PRQR)
 

Proqr Therapeutics N V 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Proqr Therapeutics N V 's Revenue per employee fell on a trailing twelve month basis to $ 1,261,040, below the company average number of $812,257.
Within the Healthcare sector Employees of 126 other companies have achieved higher revenue per employee. While Proqr Therapeutics N V 's total ranking has deteriorated compared to the previous quarter from 0 to 1292. Proqr Therapeutics N V has 24 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PRQR Revenue per Employee (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Revenue Change -15.86 % -20.24 % -36.27 % -1.53 % -
Sales per Employee (TTM) $ 1,261,040 1,400,993 1,436,596 1,539,182 1,542,258
PRQR's Total Ranking # 1292 # 0 # # #
Seq. Revenue Change 428.98 % -22.15 % -9.06 % -77.53 % 401.48 %

PRQR Company Profile >> Back to PRQR Efficiency Comparisons >> Compare PRQR Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 87
Healthcare Sector # 127
Overall Market # 1292

Revenue per Employee Statistics
High Average Low
$ 882,233 $ 812,257 $ 742,280
(Dec 31 2024)   (Dec 31 2025)



Financial Statements
Proqr Therapeutics N V 's Revenue MRQ $ 18 Millions Visit PRQR's Income Statement
Proqr Therapeutics N V 's Revenues TTM $ 30 Millions Visit PRQR's aggregate revenue growth
What are PRQR's Sales? Visit PRQR's Sales by Segment




Other Ratios
Proqr Therapeutics N V 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
PRQR's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for PRQR's Competitors
Revenue per Employee for PRQR's Suppliers
Revenue per Employee for PRQR's Customers

You may also want to know
PRQR's Sales Growth Rates PRQR's Pe Price to earnings ratio PRQR's Receivables Turnover Ratio PRQR's Stock Quote
PRQR's Net Income Growth Rates PRQR's Ps Price to Sales ratio PRQR's Sales per Employee PRQR's Asset Turnover Ratio
PRQR's Net Margin PRQR's Pb Price to Book ratio PRQR's Financial Strength Ratios PRQR's Dividend Payout Ratio
Date modified: 2026-07-07T12:40:32+00:00




Companies with similar Revenue per Employee for 12 months ending Dec 31 2025, within Healthcare Sector Revenue per Employee Revenue 12 months ending Dec 31 2025Number of Employees Dec 31 2025
Elite Pharmaceuticals Inc   2,131,496.71 $ 138.547  Million 65 
Exelixis Inc   2,022,777.68 $ 2,320.126  Million 1,147 
Biocryst Pharmaceuticals Inc   2,011,119.54 $ 874.837  Million 435 
Prestige Consumer Healthcare Inc   1,935,594.74 $ 1,103.289  Million 570 
Siga Technologies Inc  1,930,100.04 $ 94.575  Million 49 
Pharming Group N v   1,859,574.26 $ 375.634  Million 202 
Kiniksa Pharmaceuticals International Plc  1,851,267.76 $ 677.564  Million 366 
Collegium Pharmaceutical Inc   1,842,382.98 $ 779.328  Million 423 
Eton Pharmaceuticals Inc   1,812,272.73 $ 79.740  Million 44 
Incyte Corporation  1,807,750.35 $ 5,141.242  Million 2,844 
Ptc Therapeutics inc   1,746,372.35 $ 1,730.655  Million 991 
Zevra Therapeutics Inc   1,745,409.84 $ 106.470  Million 61 
Gilead Sciences Inc   1,731,941.18 $ 29,443.000  Million 17,000 
Privia Health Group Inc   1,731,518.76 $ 2,122.842  Million 1,226 
Rigel Pharmaceuticals Inc  1,691,275.86 $ 294.282  Million 174 
Cormedix Inc   1,590,770.76 $ 303.837  Million 191 
Tg Therapeutics Inc   1,544,578.95 $ 616.287  Million 399 
Arrowhead Pharmaceuticals Inc   1,534,431.79 $ 1,090.981  Million 711 
Progyny Inc   1,505,238.32 $ 1,288.484  Million 856 
Novavax inc   1,499,971.96 $ 1,123.479  Million 749 
Xenetic Biosciences Inc   1,488,205.50 $ 2.976  Million 2 
Alnylam Pharmaceuticals Inc   1,485,574.80 $ 3,713.937  Million 2,500 
Bristol myers Squibb Company  1,482,892.31 $ 48,194.000  Million 32,500 
Jazz Pharmaceuticals Plc  1,476,673.36 $ 4,267.586  Million 2,890 
Nuvation Bio Inc   1,439,139.53 $ 61.883  Million 43 
Neurocrine Biosciences Inc   1,430,250.00 $ 2,860.500  Million 2,000 
Agenus Inc  1,409,827.16 $ 114.196  Million 81 
Mirum Pharmaceuticals Inc   1,401,376.34 $ 521.312  Million 372 
Valneva Se  1,397,272.00 $ 195.618  Million 140 
Esperion Therapeutics Inc   1,371,207.48 $ 403.135  Million 294 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.